A person died in a hospital in southeastern Mexico, owned by Petróleos Mexicanos (Pemex), for allegedly receiving treatment with a contaminated drug that has four more in the intensive care unit, the state oil company said.
“The oil community regrets the fourth death of an affected patient,” Pemex said in a statement, announcing that it has given part of this death to the Attorney General of the state of Tabasco, in the southeast of the country.
With this death, there are four patients who have lost their lives in the regional hospital of Pemex in Villahermosa, Tabasco, after being treated with the drug Heparin Sodium, from a contaminated lot with an expiration date of January 2021.
The Mexican oil company said that this medicine has been used to treat 54 patients, of which 21 have no damage to their health and another six have been discharged and are still receiving outpatient treatment.
The remaining 27 are hospitalized, 23 of them are in stable condition and four in intensive therapy with continuous renal replacement. A patient receives high life support, Pemex explained.
The oil company guaranteed 100% the hemodialysis care given to the beneficiaries of its health system, which are its workers, retirees and their families.
Sodium heparin, anticoagulant, is a medicine considered antithrombotic.
According to press reports, the state company bought a batch of this drug from a private provider and not the laboratory that manufactures it, which was unmarked from its preparation and the possible handling of the product that was supposedly supplied to the hospital.
Relatives of the deceased publicly denounced that in the hospital of Pemex their patients had been given this medicine without confirming its origin.
Following this case, some patients sought alternatives and went to other hospitals for treatment.
Pemex had about 128,000 employees at the end of 2018.